Angiotensin II vascular hypertrophy part non-pressor mechanism Angiotensin II low doses blood pressure vitro vascular smooth muscle cells trophic effects effects vivo purpose vascular hypertrophy slow pressor infusion angiotensin II pressure experiments rats angiotensin II ng/kg/min minipump days Experiment Angiotensin II systolic blood pressure tail mm Hg mean SEM plasma renin threefold NS angiotensin II loss peptide pump infusate end experiment Experiment perfused mesenteric circulation vasoconstrictor responses vasopressin KCl rats slow pressor infusion angiotensin II sensitivity responses combination changes vascular hypertrophy slow pressor infusion angiotensin II Experiment Vessel myography angiotensin II infusion pressor response Angiotensin II systolic blood pressure heart weight myographic changes vascular hypertrophy mesenteric circulation media width media cross-sectional area media/lumen Hydralazine angiotensin II rise pressure cardiac effect vascular changes Two-way analysis variance angiotensin II media width media cross-sectional area media/lumen independent hydralazine hydralazine pressor cardiac effects angiotensin II pressor mechanism cardiac change structural vascular change part effect non-pressor mechanism 